Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Trial to Assess the Safety and Tolerability of the Liquid Formulation of CAIV-T in Healthy Children.

This study has been completed.
Wyeth is now a wholly owned subsidiary of Pfizer
Information provided by:
MedImmune LLC Identifier:
First received: September 13, 2005
Last updated: October 2, 2006
Last verified: October 2006
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: November 2002
  Estimated Primary Completion Date: No date given
Publications automatically indexed to this study by Identifier (NCT Number):